2025 Expert Speaker Faculty

Amanda Placone, Eli Lilly

Amanda Placone

Director

Eli Lilly

Amanda Rohrig, BridgeBio Gene Therapy

Amanda Rohrig

Patient Advocacy

BridgeBio Gene Therapy

Amber Freed

Founder & CEO

SLC6A1 Connect

Amy Raymond, PhD

Therapeutic Strategy Lead, Cellular & Genetic Medicines

Worldwide Clinical Trials

Anjulika Chawla, bluebird bio

Anjulika Chawla

Vice President, Medical Affairs, Clinical Lead

bluebird bio

Atsushi Nikishawa

Atsushi Nishikawa

Principal Reviewer

PMDA

Bennett Smith

SVP, GM, North America

Orchard Therapeutics

Brian Kevany, Abeona Therapeutics

Brian Kevany

Chief Technical Officer & Chief Scientifc Officer

Abeona Therapeutics

Craig Malzahn, REGENXBIO

Craig Malzahn

Senior Vice President, Technical Operations

REGENXBIO

Daniel Chung, SparingVision

Daniel Chung

Chief Medical Officer

SparingVision

Elizabeth Leshen, Novartis

Elizabeth Leshen

Head Of Safety, Efficiency., Gene Therapy & Rare Disease

Novartis

Eric Kelsic

Eric Kelsic

Co-Founder & Chief Executive Officer

Dyno Therapeutics

Erin Cross

Erin Cross

Vice President, Platform & Lead Development Scientist

KROMATID

Farrah Vogel-Javer

Farrah Vogel-Javeri

Customer Success Manager

Beacon

Francesca Cook

Vice President - Global Pricing & Market Access

REGENXBIO

Gail Ryan, Point32Health

Gail Ryan

Director, Pharmaceutical Transformation

Point32Health

Howard Wu, Full Circles Therapeutics

Howard Wu

Co-Founder & Chief Scientific Officer

Full Circles Therapeutics

Jean - Philippe, Vivet Therapeutics

Jean-Phillippe Combal

Co-Founder & Chief Executive Officer

Vivet Therapeutics

jennifer casagrande, speaker at 8th Gene therapy drug development summit

Jennifer Casagrande

Director of Clinical Operations

Arbor Biotechnologies

Picture of Jennifer Kingsley

Jennifer Kingsley

Chief Commercial Officer

VintaBio

Jie Li, Vertex Pharmaceuticals

Jie Li

Director Analytical Development

Vertex Pharmaceuticals

Jinpian Diao

Jinpian Diao Piezunka

Head of Technical Development

Spark Therapeutics

Josefina Nilsson

CEO

QuTEM AB

Julie Batal

Vice President - Regulatory Science

bluebird bio

Kathleen Kirby, Merlin Therapeutics

Kathleen Kirby

Principal

Viridian Strategies

Kumar Dhanasekharan, Voyager Therapeutics

Kumar Dhanasekharan

Senior Vice President & Head of Technical Operations

Voyager Therapeutics

Lucia Faccio

Partner

Sofinnova Partners

Mara Inniss, Obsidian Therapeutics

Mara Inniss

Director, Regulated Gene Editing & Gene Therapy Discovery

Obsidian Therapeutics

Mark Trusheim, Tufts Medical Center

Mark Trusheim

strategic director

Tufts Medical Center

Marriane Lopez, Duke University

Marriane Hamilton Lopez

Senior Research Director, Biomedical Innovation

Duke-Margolis Institute for Health Policy, Duke University

Maryl Lambros, Avista Therapeutics

Maryl Lambros

Bioinformatics Scientist

Avista Therapeutics

Melissa Penn, Bayer

Melissa Penn

Director, Patient Engagement R&D

Bayer

Michael Sherman

Venture Partner

RA Capital Management

Mike Lehmicke

Senior Vice President for Science & Industry Affairs

Alliance for Regenerative Medicine

Niccolo Bacchi, Borea Therapeutics

Niccolo Bacchi

Chief Executive Officer

Borea Therapeutics

Nicole Votaw

Nicole Votaw

Associate Director, R&D

Isolere Bio

Olivier Danos, REGENXBIO

Olivier Danos

Chief Scientific Officer

REGENXBIO

Prithy Martis

Prithy Martis

Operations Manager, Biologics Manufacturing Resource

Nationwide Children's Hospital

Priya Chockalingam, Beam Therapeutics

Priya Chockalingam

VP, Head of Clinical Bioanalytics & Translational Sciences

Beam Therapeutics

Rajeev Boregowda, Sanofi

Rajeev Boregowda

Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC

Sanofi

Ravi Iyer, Script Biosciences

Ravi Iyer

Chief Scientific Officer

Script Biosciences

Richard Colvin

Chief Medical Officer

bluebird bio

Picture of Richard Wilson

Richard Wilson

SVP

Astellas Pharma

Roelof Rongen

Chief Executive Officer & Board Director

Adolore Therapeutics

Samantha Smith

Samantha Smith

Principal Scientist

Carbon Biosciences

Samir Koirala, Biogen

Samir Koirala

Senior Director

Biogen

Sebastian Aguirre, Carbon Biosciences

Sebastian Aguirre Kozlouski

Co-Founder, Vice President, Head of Platform Development

Carbon Biosciences

Sitra Tauscher W, Novartis

Sitra Tauscher-Wisniewski

Vice President Clinical Development

Novartis

Terry Cothran, Oklahoma Health Care Authority

Terry Cothran

Senior Pharmacy Director

Oklahoma Health Care Authority

Uditha DeAlwis, Sarepta

Uditha DeAlwis

Vice President - Analytical Development & Quality Control

Sarepta

Van Hoang, Spark Therapeutics

Van Hoang

Head of Analytical & Quality Control

Spark Therapeutics

Vesselin Mitaksov, Pfizer

Vesselin Mitaksov

Associate Research Fellow

Pfizer

Vishwas Seshadri

President & Chief executive officer

Abeona Therapeutics

winston yan, speaker at 8th Gene therapy drug development summit

Winston Yan

Co-Founder, Head of Translational Strategy

Arbor Biotechnologies

FULL EVENT GUIDE
REGISTER
PARTNER